Biotech companies can license TeselaGen’s platform and efficiently manage complete workflows from end-to-end. Interoperability is at the core of TeselaGen’s platform as it programmatically ...
Artgen Biotech Group is investing in the development of a platform for the creation of new subunit vaccines based on surface recombinant proteins and spherical adjuvant particles. The platform makes ...
The opportunity for biotech-to-biotech collaborations is a ... This is where a drug discovery platform based on interacting molecules inside cells is very powerful. Various genomic and proteomic ...
Additionally, the long-term potential of Sana’s hypoimmune platform to extend its application ... Begin your TipRanks Premium journey today. Sana Biotechnology (SANA) Company Description ...
The collaboration of BIRAC and IAN aims to create the single largest national platform for biotech angel investing. BiAN is created as an open architecture platform to build an ecosystem conducive ...
Sana Biotechnology (NASDAQ ... has de-risked the company's hypoimmune (HIP) therapeutic platform. SANA's HIP platform, designed to allow the transplantation of cell therapies without ...
Biotech startup Exsure has raised Rs 3 crore in a funding round led by Unicorn India Ventures to advance its exosomal drug-delivery platform for anti-cancer treatments. The funds will support Exsure's ...